Search

Displaying results 9331 - 9340 of 10000 in total
  1. Drug

    PRX-03140

    go.drugbank.com/drugs/DB05596
    Investigational

  2. Drug

    Profenamine

    go.drugbank.com/drugs/DB00392
    Approved

    Profenamine (also known as ethopropazine) is a medication derived from phenothiazine. It is primarily used as an antidyskinetic to treat Parkinsonism.

  3. Drug

    Aminoimidazole carboxamide

    go.drugbank.com/drugs/DB06143
    Investigational

  4. Drug

    Semaxanib

    go.drugbank.com/drugs/DB06436
    Investigational

  5. Drug

    Fipamezole

    go.drugbank.com/drugs/DB06585
    Investigational

  6. Drug

    Posizolid

    go.drugbank.com/drugs/DB04850
    Investigational

    Posizolid (AZD2563) is an oxazolidinone antibiotic. In July 2002, after completion of phase I trials in December 2001, AstraZeneca announced that they were no longer pursuing the development of Posizolid, presumably due to negative trial...

  7. Drug

    SPP 301

    go.drugbank.com/drugs/DB05290
    Investigational

    SPP301 (Avosentan) is a potent and highly selective ET[A] receptor blocker and is clinically investigated in diabetic nephropathy.

  8. Drug

    Custirsen

    go.drugbank.com/drugs/DB05487
    Investigational

    Custirsen is a benzopyran with potential antineoplastic activity. … Custirsen acts as a selective estrogen receptor modulator (SERM), inhibiting the proliferation of estrogen-sensitive breast cancer cells.

  9. Drug

    Pelitinib

    go.drugbank.com/drugs/DB05524
    Investigational

    Pelitinib (EKB-569) is a potent, low molecular weight, selective, and irreversible inhibitor of epidermal growth factor receptor (EGFR) that is being developed as an anticancer agent.

  10. Drug

    TRU-015

    go.drugbank.com/drugs/DB05580
    Investigational